Juniper Pharma (JNP) Misses Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. STZ
4. PENG
5. SPY
6. NVDA
7. MSFT
8. SKYD
9. LEVI
10. U

Go back to Juniper Pharma (JNP) Misses Q2 EPS by 1c

Juniper Pharmaceuticals Reports Second Quarter 2015 Financial Results

August 4, 2015 7:00 AM EDT

BOSTON, Aug. 4, 2015 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the "Company") a women's health specialty pharmaceutical company, today announced financial results for the three months ended June 30, 2015. Highlights include:

Patient enrollment is underway and on track in the Phase 2 clinical study of COL-1077 10% lidocaine bioadhesive gel; Total revenues increased 53% year-over-year to $10.2 million, driven by an 89% increase in product revenues and 29% growth in service revenues; $16.1 million in cash and equivalents at... More